The pp24 phosphoprotein of Mason-Pfizer monkey virus contributes to viral genome packaging

Retrovirology

Volumn 2, Issue , 2005, Pages

  Bohl, Christopher R ^a   Brown, Shanna M ^a   Weldon Jr , Robert A ^a  

^a UNIVERSITY OF NEBRASKA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PHOSPHOPROTEIN; VIRUS DNA; VIRUS GLYCOPROTEIN; VIRUS RNA; CAPSID PROTEIN; VIRUS PROTEIN;

ARTICLE; DNA PACKAGING; GENE DELETION; GENOME ANALYSIS; LIFE CYCLE; MASON PFIZER MONKEY VIRUS; NONHUMAN; NUCLEAR PORE; NUCLEOTIDE SEQUENCE; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN SECRETION; PROTEIN TARGETING; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION; CHEMISTRY; DIMERIZATION; GENETICS; PHYSIOLOGY; VIRUS ASSEMBLY;

BETARETROVIRUS; DNA VIRUSES; MASON-PFIZER MONKEY VIRUS;

CAPSID PROTEINS; DIMERIZATION; DNA PACKAGING; GENE PRODUCTS, GAG; GENOME, VIRAL; MASON-PFIZER MONKEY VIRUS; PHOSPHOPROTEINS; RNA, VIRAL; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 27944458857     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-2-68     Document Type: Article

References (50)

1. Baillie GJ, van de Lagemaat LN, Baust C and Mager DL: Multiple groups of endogenous betaretroviruses in mice, rats, and other mammals. J Virol. 2004, 78:5784-5798.
2. Hook LM, Agafonova Y, Ross SR, Turner SJ and Golovkina TV: Genetics of mouse mammary tumor virus-induced mammary tumors: linkage of tumor induction to the gag gene. J Virol. 2000, 74:8876-8883.
3. Xu L, Sakalian M, Shen Z, Loss G, Neuberger J and Mason A: Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology. 2004, 39:151-156.
4. Power MD, Marx PA, Bryant ML, Gardner MB, Barr PJ and Luciw PA: Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus. Science. 1986, 231:1567-1572.
5. Sonigo P, Barker C, Hunter E and Wain-Hobson S: Nucleotide sequence of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus. Cell. 1986, 45:375-385.
6. Thayer RM, Power MD, Bryant ML, Gardner MB, Barr PJ and Luciw PA: Sequence relationships of type D retroviruses which cause simian acquired immunodeficiency syndrome. Virology. 1987, 157:317-329.
7. Colcher D, Heberling RL, Kalter SS and Schlom J: Squirrel monkey retrovirus: an endogenous virus of a new world primate. J Virol. 1977, 23:294-301.
8. Carlson J, Lyon M, Bishop J, Vaiman A, Cribiu E, Mornex JF, Brown S, Knudson D, DeMartini J and Leroux C: Chromosomal distribution of endogenous Jaagsiekte sheep retrovirus proviral sequences in the sheep genome. J Virol. 2003, 77:9662-9668.
9. Cousens C, Minguijon E, Dalziel RG, Ortin A, Garcia M, Park J, Gonzalez L, Sharp JM and de las Heras M: Complete sequence of enzootic nasal tumor virus, a retrovirus associated with transmissible intranasal tumors of sheep. J Virol. 1999, 73:3986-3993.
10. Kajikawa O, Dahlberg JE, Rosadio RH and De Martini JC: Detection and quantitation of a type D retrovirus gag protein in ovine pulmonary carcinoma (sheep pulmonary adenomatosis) by means of a competition radioimmunoassay. Vet Microbiol. 1990, 25:17-28.
11. Baillie GJ and Wilkins RJ: Endogenous type D retrovirus in a marsupial, the common brushtail possum (Trichosurus vulpecula). J Virol. 2001, 75:2499-2507.
12. Mager DL and Freeman JD: Novel mouse type D endogenous proviruses and ETn elements share long terminal repeat and internal sequences. J Virol. 2000, 74:7221-7229.
13. Ristevski S, Purcell DF, Marshall J, Campagna D, Nouri S, Fenton SP, McPhee DA and Kannourakis G: Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma. J Virol. 1999, 73:4662-4669.
14. Chopra HC, Bogden AE, Zelljadt I and Jensen EM: Virus particles in a transplantable rat mammary tumor of spontaneous origin. Eur J Cancer. 1970, 6:287-290.
15. Fine DL, Landon JC, Pienta RJ, Kubicek MT, Valerio MG, Loeb WF and Chopra HC: Responses of infant rhesus monkeys to inoculation with Mason-Pfizer monkey virus materials. J Natl Cancer Inst. 1975, 54:651-658.
16. Marx PA, Maul DH, Osborn KG, Lerche NW, Moody P, Lowenstine LJ, Henrickson RV, Arthur LO, Gilden RV, Gravell M and et al.: Simian AIDS: isolation of a type D retrovirus and transmission of the disease. Science. 1984, 223:1083-1086.
17. Stromberg K, Benveniste RE, Arthur LO, Rabin H, Giddens WE, Jr., Ochs HD, Morton WR and Tsai CC: Characterization of exogenous type D retrovirus from a fibroma of a macaque with simian AIDS and fibromatosis. Science. 1984, 224:289-282.
18. Freed EO: HIV-1 gag proteins: diverse functions in the virus life cycle. Virology. 1998, 251:1-15.
19. Sfakianos JN, LaCasse RA and Hunter E: The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell. Traffic. 2003, 4:660-670.
20. Rhee SS and Hunter E: A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell. 1990, 63:77-86.
21. Rhee SS and Hunter E: Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid. Embo J. 1991, 10:535-546.
22. Rhee SS and Hunter E: Structural role of the matrix protein of type D retroviruses in gag polyprotein stability and capsid assembly. J Virol. 1990, 64:4383-4389.
23. Strambio-de-Castillia C and Hunter E: Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J Virol. 1992, 66:7021-7032.
24. Sakalian M and Hunter E: Separate assembly and transport domains within the Gag precursor of Mason-Pfizer monkey virus. J Virol. 1999, 73:8073-8082.
25. Zabransky A, Sakalian M and Pichova I: Localization of self-interacting domains within betaretrovirus Gag polyproteins. Virology. 2005, 332:659-666.
26. Campbell S and Rein A: In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol. 1999, 73:2270-2279.
27. Campbell S and Vogt VM: Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol. 1995, 69:6487-6497.
28. Dupont S, Sharova N, DeHoratius C, Virbasius CM, Zhu X, Bukrinskaya AG, Stevenson M and Green MR: A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature. 1999, 402:681-685.
29. Callahan EM and Wills JW: Link between genome packaging and rate of budding for Rous sarcoma virus. J Virol. 2003, 77:9388-9398.
30. Wang H, Norris KM and Mansky LM: Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging. J Virol. 2003, 77:9431-9438.
31. Parent LJ, Cairns TM, Albert JA, Wilson CB, Wills JW and Craven RC: RNA dimerization defect in a Rous sarcoma virus matrix mutant, J Virol. 2000, 74:164-172.
32. Garbitt RA, Albert JA, Kessler MD and Parent LJ: trans-acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants. J Virol. 2001, 75:260-268.
33. Sfakianos JN and Hunter E: M-PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome. Traffic. 2003, 4:671-680.
34. Gottwein E, Bodem J, Muller B, Schmechel A, Zentgraf H and Krausslich HG: The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J Virol. 2003, 77:9474-9485.
35. Yasuda J and Hunter E: A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J Virol. 1998, 72:4095-4103.
36. Scheifele LZ, Garbitt RA, Rhoads JD and Parent LJ: Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein. Proc Natl Acad Sci U S A. 2002, 99:3944-3949.
37. Davis LI and Blobel G: Identification and characterization of a nuclear pore complex protein. Cell. 1986, 45:699-709.
38. Kramer B, Pelchen-Matthews A, Deneka M, Garcia E, Piguet V and Marsh M: HIV interaction with endosomes in macrophages and dendritic cells. Blood Cells Mol Dis. 2005, 35:136-142.
39. Nydegger S, Foti M, Derdowski A, Spearman P and Thali M: HIV-1 egress is gated through late endosomal membranes. Traffic. 2003, 4:902-910.
40. Campbell S and Vogt VM: In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles. J Virol. 1997, 71:4425-4435.
41. Paillart JC, Shehu-Xhilaga M, Marquet R and Mak J: Dimerization of retroviral RNA genomes: an inseparable pair. Nat Rev Microbiol. 2004, 2:461-472.
42. Schmidt RD, Mustafa F, Lew KA, Browning MT and Rizvi TA: Sequences within both the 5′ untranslated region and the gag gene are important for efficient encapsidation of Mason-Pfizer monkey virus RNA. Virology. 2003, 309:166-178.
43. Silver PA: How proteins enter the nucleus. Cell. 1991, 64:489-497.
44. Weldon RA, Jr., Sarkar P, Brown SM and Weldon SK: Mason-Pfizer monkey virus Gag proteins interact with the human sumo conjugating enzyme, hUbc9. Virology. 2003, 314:62-73.
45. Braun IC, Rohrbach E, Schmitt C and Izaurralde E: TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus. Embo J. 1999, 18:1953-1965.
46. Choi G, Park S, Choi B, Hong S, Lee J, Hunter E and Rhee SS: Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein. J Virol. 1999, 73:5431-5437.
47. Song C and Hunter E: Variable sensitivity to substitutions in the N-terminal heptad repeat of Mason-Pfizer monkey virus transmembrane protein. J Virol. 2003, 77:7779-7785.
48. Klikova M, Rhee SS, Hunter E and Ruml T: Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria. J Virol. 1995, 69:1093-1098.
49. Harlow EaL, David. 1988. Antibodies; A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
50. Sakalian M, Parker SD, Weldon RA, Jr. and Hunter E: Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro. J Virol. 1996, 70:3706-3715.